471 related articles for article (PubMed ID: 19284085)
1. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
Agoşton-Coldea L; Rusu LD; Zdrenghea D; Rusu ML; Pop D; Crăciun A; Poanta L; Gatfossé M; Rosenstingl S; Mocan T
Rom J Intern Med; 2008; 46(2):137-44. PubMed ID: 19284085
[TBL] [Abstract][Full Text] [Related]
2. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
[TBL] [Abstract][Full Text] [Related]
3. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
4. Apolipoproteins A-I and B-markers in coronary risk evaluation.
Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease and Lp(a) in the adult population and in the elderly: the Brisighella study.
Nascetti S; D'Addato S; Pascarelli N; Sangiorgi Z; Grippo MC; Gaddi A
Riv Eur Sci Med Farmacol; 1996; 18(5-6):205-12. PubMed ID: 9177623
[TBL] [Abstract][Full Text] [Related]
7. [Familial hypercholesterolemia and plasma Lp(a) levels: 2 cardiovascular risk factors].
Real JT; Romero G; Priego MA; Chaves FJ; Ascaso JF; Carmena R
An Med Interna; 1999 Feb; 16(2):69-72. PubMed ID: 10192997
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) as a marker of coronary artery disease and its association with dietary fat.
Burman A; Jain K; Gulati R; Chopra V; Agarwal DP; Vasisht S
J Assoc Physicians India; 2004 Feb; 52():99-102. PubMed ID: 15656041
[TBL] [Abstract][Full Text] [Related]
10. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
Habib SS; Aslam M
Saudi Med J; 2003 Jun; 24(6):647-51. PubMed ID: 12847596
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a) and cardiovascular risk in adult Mexicans.
Cardoso-Saldaña G; Ize-Lema I; Kimura LY; Zamora González J; Posadas Romero C
Rev Invest Clin; 1997; 49(2):85-92. PubMed ID: 9294956
[TBL] [Abstract][Full Text] [Related]
12. Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study.
Wang W; Lee ET; Alaupovic P; Blackett P; Blevins KS
Ann Epidemiol; 2005 May; 15(5):390-7. PubMed ID: 15840553
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) and other risk factors for cerebral infarction.
Konemori G
Hiroshima J Med Sci; 1995 Sep; 44(3):65-77. PubMed ID: 8567315
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for heart failure in patients with one prior myocardial infarction episode.
Mocan T; Agoşton-Coldea L; Gatfossé M; Rosenstingl S; Mocan LC
Rom J Intern Med; 2008; 46(3):213-21. PubMed ID: 19366080
[TBL] [Abstract][Full Text] [Related]
15. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
[TBL] [Abstract][Full Text] [Related]
16. Correlation of serum lipoprotein(a) with the clinical presentation of Thai coronary artery disease patients.
Leowattana W; Mahanonda N; Bhuripanyo K; Pokum S; Worawattananon P
J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S194-8. PubMed ID: 11194014
[TBL] [Abstract][Full Text] [Related]
17. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease.
Agoşton-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(4):341-7. PubMed ID: 18767409
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) and coronary heart disease in Indian population.
Singh S; Dwivedi S; Melkani GC; Rani C; Gaur SP; Mandal SK; Mahua J
J Assoc Physicians India; 1999 Dec; 47(12):1157-60. PubMed ID: 11225215
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
Tarkun I; Cetinarslan B; Cantürk Z
Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
